Malignant Brain Glioma — Trials

Malignant Brain Glioma — Trials · CancerIndex

Clinical trials

Registered studies

187 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 75
Recruiting: 43
Ph III recruiting: 1
Growth YoY: —
Industry share: 12%
Top sponsor: Nationwide Children's Hospital
Termination share: 40%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (32)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01236560	Vorinostat, Temozolomide, or Bevacizumab in Combination With Radiation Therapy Followed by Bevacizumab and Temozolomide in Young Patients With Newly Diagnosed High-Grade Glioma	completed	Phase 2 / Phase 3	101	National Cancer Institute (NCI)NIH	2	Feb 20, 2024	clinicaltrials
NCT00884741	Temozolomide and Radiation Therapy With or Without Bevacizumab in Treating Patients With Newly Diagnosed Glioblastoma	completed	Phase 3	637	National Cancer Institute (NCI)NIH	3	Jul 24, 2019